AYTU BIOPHARMA, INC Goodwill, Acquired During Period
AYTU BIOPHARMA, INC (AYTU) reported Goodwill, Acquired During Period of $37.71 million for the 12-month period ending 2021-06-30, per its 10-K filed 2022-09-27.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2022-09-27
- AYTU BIOPHARMA, INC goodwill, acquired during period for fiscal 2021 was $37.71M, a 34.25% increase from fiscal 2020.
- AYTU BIOPHARMA, INC goodwill, acquired during period for fiscal 2020 was $28.09M.
| Period end | Goodwill, Acquired During Period 12 month |
|---|---|
| 2021-06-30 | $37.71M 10-K · filed 2022-09-27 |
| 2020-06-30 | $28.09M 10-K · filed 2021-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |